Fix price-walking issue by end of 2021, UK tells insurers

Financial Conduct Authority revises timelines for general insurance reforms


Covid-19 UK life claims in 2020 hit £202m

ABI members expect to pay up to £2.5bn, across all lines, in pandemic claims from last year


Steven Findlay takes up Swiss Re CRO role

ABI's former head of prudential regulation returns to industry


Change Solvency II to tackle climate change, insurers say

Direct Line outlines actions to address climate change


"Pandemic Re" solutions may require mandatory purchase of cover

Barriers to creating a pandemic risk pool discussed at ABI's annual conference


Matching adjustment becomes a battleground in UK's Solvency II consultation

Respondents to the UK's consultation on the future of Solvency II have taken starkly opposing positions on the matching adjustment, with some arguing for liberalisation and others for scrapping it. Christopher Cundy reports


Bank of England ignites the debate on UK-EU Solvency II equivalence

The EU is in no rush to grant the UK reciprocal equivalence on Solvency II and has stirred anger by saying it wants to see how far the UK diverges before giving the green light. Paul Walsh assesses the state of play and whether there is any potential for a future agreement


UK motor policyholders are due a £35 Covid-19 windfall, says consumer group

The Association of British Insurers stressed motorists were benefiting from a competitive motor insurance market


Solvency II performed well during Covid-19, but challenges persist

Fitch event panellists discussed Solvency II, Covid-19 and post-pandemic recovery


Genetic testing risks go under the microscope

Do life insurers really face the risk of adverse selection from customers that have taken predictive genetic tests? Academics think not, and insurers and policyholders could indeed benefit from wider use of genetic testing, as Paul Walsh reports